Suicide Rates and Prescription of Antidepressants
Trends in the United States, 1999–2020, by Sex and Race/Ethnicity
Abstract
Abstract:Background: Previous ecological studies reported that increasing antidepressant prescriptions were associated with decreasing suicide rates. Aim: To determine whether antidepressant prescription prevalence is negatively associated with suicide rates (i.e., as antidepressant prescribing increases, suicide rates decrease) between 1999 and 2020. Method: The study protocol was pre-registered on the Open Science Framework (https://osf.io/978sk/). Publicly available data from the Centers for Disease Control and Prevention’s Wide-Ranging Online Data for Epidemiological Research (CDC WONDER) and Medical Expenditure Panel Survey (MEPS) were used. Results: Overall, both the antidepressant prescription prevalence and the suicide rate were increasing from 1990 to 2020 in the United States. Positive trends for both outcomes were also evident when analyses were stratified according to sex and/or race/ethnicity. Pearson’s correlation analyses consistently found positive associations between antidepressant prescription prevalence and suicide rates. Limitations: Trends and their associations were examined at the population level. The results cannot clarify the causal nature of the association observed. Conclusion: The results of our analysis consistently demonstrated positive trends for both antidepressant prescription prevalence and suicide rates over time as well as positive associations between them. These findings update those from previous studies and are at odds with the notion that, at a population level, more antidepressant prescriptions would lead to lower suicide rates. However, it needs to be acknowledged that ecological studies provide insufficient evidence to infer causality.
References
2021). Did the introduction and increased prescribing of antidepressants lead to changes in long-term trends of suicide rates? European Journal of Public Health, 31(2), 291–297. 10.1093/eurpub/ckaa204
(2017). Suicidal risks in reports of long-term controlled trials of antidepressants for major depressive disorder II. International Journal of Neuropsychopharmacology, 20(3), 281–284. 10.1093/ijnp/pyw092
(2007). Ecological studies of antidepressant treatment and suicidal risks. Harvard Review of Psychiatry, 15(4), 133–145. 10.1080/10673220701551102
(2016). Suicides and suicide attempts during long-term treatment with antidepressants: A meta-analysis of 29 placebo-controlled studies including 6,934 patients with major depressive disorder. Psychotherapy and Psychosomatics, 85(3), 171–179. 10.1159/000442293
(2005). Antidepressants and the suicide rate: Is there really a connection? Advances in Health Economics and Health Services Research, 16, 121–141. 10.1016/S0731-2199(05)16006-3
(2004). Antidepressants and suicide risk in the United States, 1985–1999. Journal of Clinical Psychiatry, 65(11), 1456–1462. 10.4088/jcp.v65n1103
(2013). Antidepressant utilization and suicide in Europe: An ecological multi-national study. PLoS ONE, 8(6), Article
(e66455 . 10.1371/journal.pone.00664552018). Suicide mortality in the United States, 1999–2017. National Center for Health Statistics. https://www.cdc.gov/nchs/products/databriefs/db330.htm
(2021). Suicide risk with selective serotonin reuptake inhibitors and other new-generation antidepressants in adults: A systematic review and meta-analysis of observational studies. Journal of Epidemiology and Community Health, 75(6), 523–530. 10.1136/jech-2020-214611
(2019). Newer-Generation antidepressants and suicide risk in randomized controlled trials: A re-analysis of the FDA database. Psychotherapy and Psychosomatics, 88(4), 247–248. 10.1159/000501215
(2019). Economic crises and suicides between 1970 and 2011: Time trend study in 21 developed countries. Journal of Epidemiology and Community Health, 73(4), 311–316. 10.1136/jech-2018-210781
(2010). The increased use of antidepressants has contributed to the worldwide reduction in suicide rates. British Journal of Psychiatry, 196(6), 429–433. 10.1192/bjp.bp.109.076166
(2000). Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine, 19(3), 335–351. 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z
(2004). Comparability of segmented line regression models. Biometrics, 60(4), 1005–1014. 10.1111/j.0006-341X.2004.00256.x
(2011). Impact of business cycles on US suicide rates, 1928-2007. American Journal of Public Health, 101(6), 1139–1146. 10.2105/AJPH.2010.300010
(2005). Suicide prevention strategies: A systematic review. JAMA, 294(16), 2064–2074. 10.1001/jama.294.16.2064
(2019). Suicide rates among adolescents and young adults in the United States, 2000–2017. JAMA, 321(23), 2362–2364. 10.1001/jama.2019.5054
(2022). Joinpoint Regression Program (Version 4.9.1.0). https://surveillance.cancer.gov/help/joinpoint
. (2019). Antidepressant prescription rates and suicide attempt rates from 2004 to 2016 in a nationally representative sample of adolescents in the USA. Epidemiology and Psychiatric Sciences, 28(5), 589–591. 10.1017/S2045796018000136
(2020). Commentary to “antidepressants and suicidality: A re-analysis of the re-analysis”. Journal of Affective Disorders, 273, 252–253. 10.1016/j.jad.2020.04.025
(2006). Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries. British Journal of Psychiatry, 188(4), 354–358. 10.1192/bjp.188.4.354
(2007). Do antidepressants reduce suicide rates? Public Health, 121(4), 274–277. 10.1016/j.puhe.2006.09.024
(2009). Risk of suicidality in clinical trials of antidepressants in adults: Analysis of proprietary data submitted to US Food and drug Administration. BMJ, 339, Article
(b2880 . 10.1136/bmj.b28802010). The relationship between sales of SSRI, TCA and suicide rates in the Nordic countries. BMC Psychiatry, 10, Article
(62 . 10.1186/1471-244X-10-622016). Suicide prevention strategies revisited: 10-year systematic review. The Lancet Psychiatry, 3(7), 646–659. 10.1016/S2215-0366(16)30030-X
(